Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Capital Expenditures: 2010-2024

Historic Capital Expenditures for CorMedix (CRMD) over the last 13 years, with Dec 2024 value amounting to $115,730.

  • CorMedix's Capital Expenditures rose 5078.93% to $505,774 in Q3 2025 from the same period last year, while for Sep 2025 it was $549,765, marking a year-over-year increase of 355.76%. This contributed to the annual value of $115,730 for FY2024, which is 64.64% down from last year.
  • As of FY2024, CorMedix's Capital Expenditures stood at $115,730, which was down 64.64% from $327,300 recorded in FY2023.
  • CorMedix's 5-year Capital Expenditures high stood at $1.4 million for FY2021, and its period low was $112,638 during FY2020.
  • For the 3-year period, CorMedix's Capital Expenditures averaged around $220,797, with its median value being $219,360 (2022).
  • As far as peak fluctuations go, CorMedix's Capital Expenditures skyrocketed by 1,165.41% in 2021, and later crashed by 84.61% in 2022.
  • Yearly analysis of 5 years shows CorMedix's Capital Expenditures stood at $112,638 in 2020, then soared by 1,165.41% to $1.4 million in 2021, then plummeted by 84.61% to $219,360 in 2022, then skyrocketed by 49.21% to $327,300 in 2023, then tumbled by 64.64% to $115,730 in 2024.